Your browser doesn't support javascript.
loading
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial.
Zhang, Jun-Jie; Ye, Fei; Xu, Kai; Kan, Jing; Tao, Ling; Santoso, Teguh; Munawar, Muhammad; Tresukosol, Damras; Li, Li; Sheiban, Imad; Li, Feng; Tian, Nai-Liang; Rodríguez, Alfredo E; Paiboon, Chotnoparatpat; Lavarra, Francesco; Lu, Shu; Vichairuangthum, Kitigon; Zeng, Hesong; Chen, Lianglong; Zhang, Ruiyan; Ding, Shiqin; Gao, Fengtang; Jin, Zening; Hong, Lang; Ma, Likun; Wen, Shangyu; Wu, Xueming; Yang, Song; Yin, Wei-Hsian; Zhang, Jun; Wang, Yan; Zheng, Yonghong; Zhou, Lei; Zhou, Limin; Zhu, Yuansheng; Xu, Tan; Wang, Xin; Qu, Hong; Tian, Yulong; Lin, Song; Liu, Lijun; Lu, Qinghua; Li, Qihua; Li, Bo; Jiang, Qing; Han, Leng; Gan, Guojun; Yu, Mengyue; Pan, Defeng; Shang, Zhenglu.
Afiliação
  • Zhang JJ; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China.
  • Ye F; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China.
  • Xu K; Division of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
  • Kan J; Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China.
  • Tao L; Division of Cardiology, Xijing Hospital, 4th Military Medical University, Xi'an, China.
  • Santoso T; Division of Cardiology, Medistra Hospital, University of Indonesia Medical School, Jakarta, Indonesia.
  • Munawar M; Division of Cardiology, Binawaluya Cardiac Center, Jakarta, Indonesia.
  • Tresukosol D; Division of Cardiology, Medicine Siriraj Hospital, Bangkok, Thailand.
  • Li L; Division of Cardiology, Guangzhou Red Cross Hospital, Guangzhou, China.
  • Sheiban I; Division of Cardiology, Pederzoli Hospital-Peschiera del Garda, Verona, Italy.
  • Li F; Division of Cardiology, Oriental General Hospital, Huainan, China.
  • Tian NL; Division of Cardiology, Nanjing Heart Center, Nanjing, China.
  • Rodríguez AE; Division of Cardiology, Otamendi Hospital, Buenos Aires, Argentina.
  • Paiboon C; Division of Cardiology, Bangkok General Hospital, Bangkok, Thailand.
  • Lavarra F; Division of Cardiology, Jilin Cardiovascular Hospital, Changchun, China.
  • Lu S; Division of Cardiology, Taicang 1st People's Hospital, Taicang, China.
  • Vichairuangthum K; Division of Cardiology, Bangplee Hospital, Bangkok, Thailand.
  • Zeng H; Division of Cardiology, Wuhan Tongji Hospital, United Medical University, Wuhan, China.
  • Chen L; Division of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart Medical Center, Fuzhou, China.
  • Zhang R; Division of Cardiology, Shanghai Ruijin Hospital, Shanghai Communication University, Shanghai, China.
  • Ding S; Division of Cardiology, Xinhua Hospital, Huainan, China.
  • Gao F; Division of Cardiology, Gansu Provincial People's Hospital, Lanzhou, China.
  • Jin Z; Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Hong L; Division of Cardiology, Jiangxi Provincial People's Hospital, Nanchang, China.
  • Ma L; Division of Cardiology, Anhui Provincial Hospital, Hefei, China.
  • Wen S; Division of Cardiology, Tianjin 4th Central Hospital, Tianjin, China.
  • Wu X; Division of Cardiology, Wuxi 3rd People's Hospital, Wuxi, China.
  • Yang S; Division of Cardiology, Yixing People's Hospital, Yixing, China.
  • Yin WH; Division of Cardiology, Cheng-Hsin General Hospital, Taipei, China.
  • Zhang J; Division of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
  • Wang Y; Division of Cardiology, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China.
  • Zheng Y; Division of Cardiology, Jintan Traditional Chinese Medicine Hospital, Jintan, China.
  • Zhou L; Division of Cardiology, Liyang Hospital of Traditional Chinese Medicine, Liyang, China.
  • Zhou L; Division of Cardiology, Chuzhou People's Hospital, Chuzhou, China.
  • Zhu Y; Division of Cardiology, Huaian 2nd People's Hospital, Huaian, China.
  • Xu T; Division of Cardiology, Xinyang Central Hospital, Xinyang, China.
  • Wang X; Division of Cardiology, Lianyungang Traditional Chinese Medicine Hospital, Lianyungang, China.
  • Qu H; Division of Cardiology, XuanCheng Central Hospital, Xuancheng, China.
  • Tian Y; Division of Cardiology, Xuyi People's Hospital, Xuyi, China.
  • Lin S; Division of Cardiology, Jintan People's Hospital, Jintan, China.
  • Liu L; Division of Cardiology, Huainan People's Hospital, Huainan, China.
  • Lu Q; Division of Cardiology, 2nd People's Hospital, Shandong University, Jinan, China.
  • Li Q; Division of Cardiology, Changzhou Traditional Chinese Medicine Hospital, China.
  • Li B; Division of Cardiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Jiang Q; Division of Cardiology, Anqing 1st People's Hospital, Anqing, China.
  • Han L; Division of Cardiology, Changshu People's Hospital, Changshu, China.
  • Gan G; Division of Cardiology, 17th Metallurgical Hospital, Maanshan, China.
  • Yu M; Division of Cardiology, Qingdao Campus of Fuwai Hospital, Qingdao, China.
  • Pan D; Division of Cardiology, Xuzhou 2nd People's Hospital, Xuzhou, China.
  • Shang Z; Division of Cardiology, Wuxi Huishan District People's Hospital, Wuxi, China.
Eur Heart J ; 41(27): 2523-2536, 2020 07 14.
Article em En | MEDLINE | ID: mdl-32588060
ABSTRACT

AIM:

The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions. METHODS AND

RESULTS:

In total, 653 patients with complex bifurcation lesions at 49 international centres were randomly assigned to undergo the systematic two-stent technique (two-stent group) or provisional stenting (provisional group). The primary endpoint was the composite of target lesion failure (TLF) at the 1-year follow-up, including cardiac death, target vessel myocardial infarction (TVMI), and clinically driven target lesion revascularization (TLR). The safety endpoint was definite or probable stent thrombosis. At the 1-year follow-up, TLF occurred in 37 (11.4%) and 20 (6.1%) patients in the provisional and two-stent groups, respectively [77.8% double-kissing crush; hazard ratio (HR) 0.52, 95% confidence interval (CI) 0.30-0.90; P = 0.019], largely driven by increased TVMI (7.1%, HR 0.43, 95% CI 0.20-0.90; P = 0.025) and clinically driven TLR (5.5%, HR 0.43, 95% CI 0.19-1.00; P = 0.049) in the provisional group. At the 1 year after indexed procedures, the incidence of cardiac death was 2.5% in the provisional group, non-significant to 2.1% in the two-stent group (HR 0.86, 95% CI 0.31-2.37; P = 0.772).

CONCLUSION:

For DEFINITION criteria-defined complex coronary bifurcation lesions, the systematic two-stent approach was associated with a significant improvement in clinical outcomes compared with the provisional stenting approach. Further study is urgently warranted to identify the mechanisms contributing to the increased rate of TVMI after provisional stenting. STUDY REGISTRATION http//www.clinicaltrials.com; Identifier NCT02284750.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article